The Batten Disease Family Association is a national charity which aims to support families, raise awareness and facilitate research into the group of devastating neurodegenerative diseases commonly known as Batten disease.
Networks
The Batten Disease Family Association is a national charity which aims to support families, raise awareness and facilitate research into the group of devastating neurodegenerative diseases commonly known as Batten disease.
637 North 7th Street, Suite 102 PO Box 12468 Beaumont, TX 77726-2468 Telephone: 409-832-0788 Fax: 409-832-0890 E-mail: [email protected] Website: http://www.blepharospasm.org
Genetics Home Reference, Your Guide to Understanding Genetics Disorders
Beyond Batten Disease Foundation is spearheading a unique, cohesive strategy that incorporates independent scientific resources and collaborations with related funding organizations to drive research into Batten Disease. See how Beyond Batten Disease Foundation is working with academia, the pharmaceutical industry, and government agencies to cross the “Valley of Death” between...
Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec’s significant products that address diseases such...
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company’s product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I...
BioMS Medical is a Canadian biotech company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical has obtained an exclusive worldwide license to a proprietary technology developed at the MS Patient Care and Research Clinic at the University of Alberta for the treatment of MS. The technology,...
Bioneur offers a simple, pragmatic, efficient and cost effective orphan drug specific business model that 1) enables physicians to treat his/her patient(s) suffering from a debilitating/life-threatening orphan disease and 2) enables emerging biopharmaceutical companies to commercially develop international markets sooner than anticipated.
Bioniz is leveraging its unique expertise in cytokine biology to develop an entirely new class of human therapeutics targeting cytokines and their receptors. Bioniz platform technology allows custom design of its lead program to create novel peptides which selectively inhibit multiple cytokines without compromising the rest of the immune system....
The company began operations in 1996 with the initial aim of supplying business intelligence products and services to the life sciences industry. Since then, we developed a novel, unique and state-of-the art technology that has allowed us to offer distinct value in basic research, clinical development and consumer health, in...
Birt-Hogg-Dubé syndrome (BHD)
Birt-Hogg-Dubé syndrome (BHD)
Birth Defect Research for Children is a non-profit organization that sponsors the National Birth Defect Registry and provides parents with information and support services for their children. BDRC has a parent-matching program that links families who have children with similar birth defects. BDRC also sponsors the National Birth Defect Registry, a...